Janney Montgomery Scott’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.4M | Sell |
297,310
-39,471
| -12% | -$2.14M | 0.04% | 407 |
|
|
2025
Q4 | $16.5M | Sell |
336,781
-8,557
| -2% | -$399K | 0.04% | 429 |
|
|
2025
Q3 | $14.9M | Buy |
345,338
+8,767
| +3% | +$342K | 0.04% | 464 |
|
|
2025
Q2 | $12.9M | Buy |
336,571
+31,176
| +10% | +$1.19M | 0.03% | 460 |
|
|
2025
Q1 | $11.8M | Buy |
305,395
+13,239
| +5% | +$485K | 0.03% | 477 |
|
|
2024
Q4 | $9.88M | Sell |
292,156
-2,650
| -0.9% | -$95.4K | 0.03% | 535 |
|
|
2024
Q3 | $12.1M | Sell |
294,806
-16,256
| -5% | -$665K | 0.03% | 478 |
|
|
2024
Q2 | $12M | Sell |
311,062
-35,123
| -10% | -$1.48M | 0.04% | 452 |
|
|
2024
Q1 | $14.8M | Buy |
346,185
+32,979
| +11% | +$1.36M | 0.04% | 411 |
|
|
2023
Q4 | $11.6M | Sell |
313,206
-261,800
| -46% | -$9.4M | 0.04% | 455 |
|
|
2023
Q3 | $20.8M | Sell |
575,006
-17,551
| -3% | -$623K | 0.08% | 244 |
|
|
2023
Q2 | $21.1M | Buy |
592,557
+28,576
| +5% | +$1.03M | 0.07% | 251 |
|
|
2023
Q1 | $20.1M | Buy |
563,981
+251,184
| +80% | +$8.79M | 0.08% | 231 |
|
|
2022
Q4 | $11M | Sell |
312,797
-13,218
| -4% | -$440K | 0.04% | 399 |
|
|
2022
Q3 | $9.6M | Sell |
326,015
-5,196
| -2% | -$197K | 0.04% | 397 |
|
|
2022
Q2 | $18M | Buy |
331,211
+2,741
| +0.8% | +$151K | 0.08% | 231 |
|
|
2022
Q1 | $17.9M | Buy |
328,470
+4,154
| +1% | +$226K | 0.08% | 235 |
|
|
2021
Q4 | $17.9M | Sell |
324,316
-5,870
| -2% | -$305K | 0.07% | 258 |
|
|
2021
Q3 | $15.8M | Buy |
330,186
+31,042
| +10% | +$1.56M | 0.07% | 262 |
|
|
2021
Q2 | $14.9M | Sell |
299,144
-26,374
| -8% | -$1.27M | 0.07% | 272 |
|
|
2021
Q1 | $14.5M | Buy |
325,518
+34,772
| +12% | +$1.58M | 0.07% | 244 |
|
|
2020
Q4 | $13.4M | Sell |
290,746
-45,624
| -14% | -$2.1M | 0.06% | 269 |
|
|
2020
Q3 | $15.8M | Sell |
336,370
-6
| -0% | -$301 | 0.09% | 215 |
|
|
2020
Q2 | $17.2M | Sell |
336,376
-3,302
| -1% | -$169K | 0.11% | 198 |
|
|
2020
Q1 | $16.1M | Buy |
339,678
+12,592
| +4% | +$672K | 0.13% | 185 |
|
|
2019
Q4 | $19.2M | Buy |
327,086
+21,292
| +7% | +$1.18M | 0.13% | 186 |
|
|
2019
Q3 | $16.3M | Buy |
305,794
+6,662
| +2% | +$343K | 0.12% | 189 |
|
|
2019
Q2 | $15M | Buy |
299,132
+6,284
| +2% | +$315K | 0.11% | 199 |
|
|
2019
Q1 | $15.3M | Buy |
292,848
+3,144
| +1% | +$157K | 0.13% | 189 |
|
|
2018
Q4 | $13.8M | Sell |
289,704
-1,318
| -0.5% | -$64.9K | 0.13% | 172 |
|
|
2018
Q3 | $14.6M | Buy |
291,022
+2,268
| +0.8% | +$115K | 0.13% | 185 |
|
|
2018
Q2 | $14.6M | Buy |
288,754
+101
| +0% | +$5.09K | 0.14% | 163 |
|
|
2018
Q1 | $14.1M | Buy |
288,653
+85,447
| +42% | +$3.98M | 0.14% | 166 |
|
|
2017
Q4 | $9.01M | Buy |
203,206
+480
| +0.2% | +$22.2K | 0.09% | 230 |
|
|
2017
Q3 | $10.3M | Sell |
202,726
-760
| -0.4% | -$38.6K | 0.12% | 205 |
|
|
2017
Q2 | $11M | Buy |
203,486
+6,804
| +3% | +$363K | 0.14% | 181 |
|
|
2017
Q1 | $10.4M | Sell |
196,682
-3,936
| -2% | -$200K | 0.14% | 176 |
|
|
2016
Q4 | $9.66M | Buy |
200,618
+24,140
| +14% | +$1.19M | 0.15% | 172 |
|
|
2016
Q3 | $9.51M | Buy |
+176,478
| New | +$9.68M | 0.17% | 143 |
|
|
2016
Q2 | – | Sell |
-128,985
| Closed | -$6.54M | – | 896 |
|
|
2016
Q1 | $6.54M | Buy |
128,985
+10,459
| +9% | +$521K | 0.17% | 142 |
|
|
2015
Q4 | $5.98M | Buy |
118,526
+4,603
| +4% | +$235K | 0.15% | 159 |
|
|
2015
Q3 | $5.47M | Sell |
113,923
-16,977
| -13% | -$884K | 0.15% | 160 |
|
|
2015
Q2 | $6.81M | Buy |
130,900
+6,604
| +5% | +$372K | 0.14% | 170 |
|
|
2015
Q1 | $7.17M | Sell |
124,296
-2,036
| -2% | -$117K | 0.13% | 188 |
|
|
2014
Q4 | $6.75M | Buy |
126,332
+14,994
| +13% | +$839K | 0.14% | 182 |
|
|
2014
Q3 | $6.4M | Buy |
111,338
+42,836
| +63% | +$2.63M | 0.13% | 182 |
|
|
2014
Q2 | $4.58M | Buy |
68,502
+11,731
| +21% | +$794K | 0.1% | 252 |
|
|
2014
Q1 | $3.79M | Buy |
56,771
+4,016
| +8% | +$271K | 0.09% | 274 |
|
|
2013
Q4 | $3.52M | Buy |
52,755
+3,797
| +8% | +$246K | 0.09% | 264 |
|
|
2013
Q3 | $3.07M | Buy |
48,958
+24,993
| +104% | +$1.61M | 0.09% | 275 |
|
|
2013
Q2 | $1.5M | Buy |
+23,965
| New | +$1.52M | 0.16% | 153 |
|
Other funds holding GSK
JEST
